Begin main content

Reports

We found 88 result(s)

bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy)

Last Updated: October 30, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: bictegravir/emtricitabine/tenofovir alafenamide
Indications: HIV-1 infection

  • Brand Name: Biktarvy
  • Manufacturer: Gilead Sciences Canada, Inc.
  • Project Number: SR0567-000
  • Project Status: Complete
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV, HIV-1, HIV/AIDS, Infectious diseases, BFTAF; Bictegravir; emtricitabine; tenofovir; tenofovir alafenamide; Human immunodeficiency virus; human immunodeficiency virus-1; HIV

isavuconazole (Cresemba)

Last Updated: November 5, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: isavuconazole
Indications: Treatment of invasive aspergillosis and mucormycosis.

  • Brand Name: Cresemba
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0586-000
  • Project Status: Received
  • Submission Type: New

Tags

Infectious Diseases, Nervous System, Infectious diseases, Nervous system, Respiratory

Tesamorelin (Egrifta)

Last Updated: October 10, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Tesamorelin
Indications: Lipodystrophy, HIV-infected patients

  • Brand Name: Egrifta
  • Manufacturer: Theratechnologies Inc.
  • Project Number: SR0477-000
  • Project Status: Complete
  • Submission Type: New

Tags

Lipodystrophy, HIV/AIDS, Infectious diseases

Topical Antibiotics for the Treatment of Treatment-Resistant Impetigo: Clinical Effectiveness and Guidelines

Published on: October 4, 2018
Result type: Reports
Product Line: Rapid Response
Research Type: Drug

  • Project Number: RA0968-000

Tags

Dermatology, Infectious Diseases, Administration, Topical, Bacitracin, Gramicidin, Impetigo, Mupirocin, Silver Sulfadiazine, Dermatology, Infectious diseases, ozenoxacin, polymyxin, silver sufadiazine, fusidic acid, mupirocin, bacitracin, topical ointment, topical administration, impetigo

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (Symtuza)

Last Updated: August 8, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide
Indications: HIV-1 infection

  • Brand Name: Symtuza
  • Manufacturer: Janssen Inc.
  • Project Number: SR0552-000
  • Project Status: Complete
  • Submission Type: New

Tags

Infectious Diseases, Anti-Retroviral Agents, HIV, HIV/AIDS, Infectious diseases, Symtuza; darunavir; cobicistat; emtricitabine; tenofovir alafenamide; HIV; Antiretroviral

Health Technology Update — Issue 21

Published on: August 7, 2018
Result type: Reports
Product Line: Health Technology Update
opens in document viewer

This issue of Health Technology Update features brief summaries of information on a range of technologies with relevance to rural and remote health care settings — from medical drones to a teleoperated robotic ultrasound system. These technologies were identified through the CADTH Horizon Scanning Service as topics of potential inter...

  • Project Number: EN0011-000

Tags

Artificial Intelligence, Infectious Diseases, Telehealth, Telemedicine, Tuberculosis, Imaging, Infectious diseases, Medical devices, Other miscellaneous topics, Telehealth, FebriDx, Indigenous peoples’ health, diabetic retinopathies, drone, drones, remote ultrasound, robotic ultrasound, teleopthalmology, teleretinal, unmanned aerial vehicle, unmanned aerial vehicles

letermovir (Prevymis)

Last Updated: July 9, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: letermovir
Indications: Cytomegalovirus infection, prophylaxis

  • Brand Name: Prevymis
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0545-000
  • Project Status: Complete
  • Submission Type: New

Tags

Infectious Diseases, Cystinosis, Delayed-Action Preparations, HIV/AIDS, Infectious diseases, cysteamine bitartrate; Procysbi; nephropathic; cystinosis; extended release; delayed action; delayed release; controlled release; Long acting; time release

Dolutegravir / rilpivirine (Juluca)

Last Updated: June 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dolutegravir rilpivirine
Indications: HIV infection

  • Brand Name: Juluca
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0551-000
  • Project Status: Complete
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV, Human Immunodeficiency Virus Proteins, HIV/AIDS, Infectious diseases, HIV; rilpivirine; dolutegravir; Juluca; human immuno-deficiency virus; Human immunodeficiency virus; human immuno-deficiency viruses; human immunodeficiency viruses